STRYKER CORP (SYK)
About STRYKER CORP
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $25.1B
- Net income
- $3.2B
- Total assets
- $47.8B
- Market cap
- $117.2B
- Gross margin
- 64.0%
- Operating margin
- 19.5%
- Net margin
- 12.9%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $25.1B
- Cost of revenue
- $9.1B
- Gross profit
- $16.1B
- Operating expenses
- $11.2B
- Operating income
- $4.9B
- Income tax
- $1.3B
- Net income
- $3.2B
- EPS (basic)
- $8.49
- EPS (diluted)
- $8.40
Balance sheet
- Total assets
- $47.8B
- Current assets
- $14.8B
- Total liabilities
- $25.4B
- Current liabilities
- $7.8B
- Shareholders’ equity
- $22.4B
Cash flow
- Operating cash flow
- $5.0B
- Investing cash flow
- -$4.9B
- Financing cash flow
- $113.0M
- Net cash flow
- $359.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $117.2B
- P/E ratio
- 39.3
- EPS (diluted)
- $8.4
- Dividend yield
- 1.07%
- Shares outstanding
- 354.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 2, 1979
Stryker Corp (SYK) Stock Price
- Profitable — net income of $3.2B in FY2025.
- Revenue grew 75% from FY2020 to FY2025.
- Gross margin of 64.0%, net margin 12.9%.
- Trading 18% below its 52-week high.
- Pays a dividend yielding about 1.07% annually.
- Valued at a price-to-earnings (P/E) ratio of 39.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review STRYKER CORP.
Write a review
News about STRYKER CORP
News & sentiment via Polygon.io
Stryker Corp: frequently asked questions
Is Stryker Corp an American company?
Yes — Stryker Corp is an American company headquartered in Portage, Michigan. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Stryker Corp headquartered?
Stryker Corp is headquartered in Portage, Michigan, United States.
Is Stryker Corp publicly traded?
Yes — Stryker Corp is a publicly traded company. Its stock trades under the ticker symbol SYK on the NYSE.
What does Stryker Corp do?
Stryker Corp is an American Medical Devices company in the Health & Beauty sector.
When was Stryker Corp founded?
Stryker Corp was founded in 1946.
